Partner Therapeutics

Building upon a strong foundation of expertise in oncology, PTx also leads and supports groundbreaking research in infectious disease and other areas of clinical urgency, including treatment of the novel coronavirus (COVID-19). With integrated capabilities in research, manufacturing, development, and commercialization, the PTx team works rapidly to bring therapies to patients who need them most around the world. This focus on collaboration and partnership enables us to move development programs forward with an efficient and streamlined approach.